These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2835416)

  • 21. Transcatheter oily chemoembolization with high doses of adriamycin in the treatment of large hepatocellular carcinoma (10 cm or more in diameter).
    Nakamura H; Hashimoto T; Inoue Y; Inoue K; Akaji H; Sawada S
    Radiat Med; 1990; 8(5):188-90. PubMed ID: 1963695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intra-arterial infusion and chemo-embolization therapy for hepatocellular carcinoma using lipiodol and cisplatin].
    Kasugai H; Kojima J; Tatsuta M; Tanaka S; Okuda S; Sasaki Y; Imaoka S; Fujita M
    Nihon Shokakibyo Gakkai Zasshi; 1988 Feb; 85(2):207-16. PubMed ID: 2455080
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sodium thiosulfate on cisplatin removal after intra-arterial embolization with a lipiodol-platinum suspension for hepatocellular carcinoma.
    Tamura Y; Ikeda O; Nakasone Y; Iryo Y; Yamashita Y
    Acta Radiol; 2010 May; 51(4):383-8. PubMed ID: 20192896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transcatheter arterial infusion therapy using lipiodol and mitomycin C for hepatocellular carcinoma with liver cirrhosis].
    Adachi S; Todoroki T; Ishikawa A; Nosue M; Fukao K; Iwasaki Y; Saida Y; Yamaguchi T; Osuga T; Doi M
    Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1710-9. PubMed ID: 2848081
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
    Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
    Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension].
    Takeda M; Mizuguchi N; Ohyama Y; Suzuki S; Itoh M; Mukojima T; Kumagai T; Iwasaki H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1367-70. PubMed ID: 1648891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis.
    Nagamatsu H; Hiraki M; Mizukami N; Yoshida H; Iwamoto H; Sumie S; Torimura T; Sata M
    Aliment Pharmacol Ther; 2010 Aug; 32(4):543-50. PubMed ID: 20500734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transarterial "pile-up" infusion therapy of cisplatin and lipiodol emulsion in hepatic malignancies without TAE (transcatheter arterial embolization)].
    Onohara S; Ogita M; Shimada J; Hiraki Y; Abeyama K; Nakajo M
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):315-21. PubMed ID: 1311912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [-Comparison of lipiodol-assisted chemoembolization versus only conservative therapy in patients with nonresectable hepatocellular carcinomas-].
    Lorenz M; Waldeyer M; Müller HH
    Z Gastroenterol; 1996 Mar; 34(3):205-6. PubMed ID: 8650976
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of lipiodol-cisplatinum arterial infusion chemotherapy on cellular immunity].
    Ohsumi M; Koitabashi H; Nagamachi Y; Iijima T
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):327-31. PubMed ID: 1311914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma.
    Brans B; Van Laere K; Gemmel F; Defreyne L; Vanlangenhove P; Troisi R; Van Vlierberghe H; Colle I; De Hemptinne B; Dierckx RA
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):928-32. PubMed ID: 12111134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assessment of therapeutic effects of cisplatin-phosphatidyl-choline-lipiodol (CPL) suspension for hepatocellular carcinoma].
    Sakata K; Hirai K; Izyuin H; Noguchi H; Ono N; Aoki Y; Tanikawa K; Okano Y; Tomita Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1847-50. PubMed ID: 1652224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
    Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
    Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intra-arterial injection of cisplatin suspension in Lipiodol (LPS) in the treatment of hepatocellular carcinoma].
    Fukushima S; Kishimoto S; Hayashi Y; Nakano M; Shibata J; Fujiyama S; Sato T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3062-5. PubMed ID: 2551247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intra-arterial injection of cisplatin suspension in lipiodol (LPS) for the treatment of advanced hepatocellular carcinoma (stage IV)].
    Shibata J; Kimura S; Nakashima M; Nakazono K; Miyase S; Sakai M; Fujiyama S; Sato T
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):357-64. PubMed ID: 2539053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study.
    Baur M; Walter R; Gebauer A; Tscholakoff D; Lochs H; Mühlbacher F; Turetschek K; Binder R; Hudec M; Gangl A; Ferenci P; Dittrich C
    Int J Oncol; 2003 Sep; 23(3):811-9. PubMed ID: 12888922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of hepatocellular carcinoma effectively treated by intraarterial infusion of CDDP and other agents].
    Yodono H; Tarusawa K; Sasaki T; Kanehira J; Saito Y; Takahashi S; Kimura T; Nishi N; Nakamura Y; Takekawa S
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3265-8. PubMed ID: 2551253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.